Dexamethasone or Clonidine as Adjuncts to Ropivacaine for Caudal Analgesia on Analgesia Duration in Children
NCT02773602 is a phase 4 interventional trial sponsored by The University of Texas Health Science Center, Houston. As of 18 Nov 2026, it has a status the registry marks as unknown. It studies Clonidine, Dexamethasone and Normal Saline in Postoperative Pain. The registry lists an enrollment of 155 participants at 1 site in 1 country. The registry lists a start date of 31 May 2011 and a primary completion date of 31 Dec 2016.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT02773602 |
| Status | Unknown |
| Phase | Phase 4 |
| Study type | Interventional trial |
| Lead sponsor | The University of Texas Health Science Center, Houston |
| Enrollment | 155 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Postoperative Pain |
| Drugs | Clonidine, Dexamethasone and Normal Saline |
| Start | 31 May 2011 |
| Primary completion | 31 Dec 2016 |
| Study completion | 31 Dec 2017 |
| Last update posted | 16 May 2016 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Samia N Khalil, (M.B; B.CH)
The University of Texas Health Science Center, Houston
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Memorial Hermann Hospital
Houston
Samia N Khalil, (M.B; B.CH)Recruiting
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT02773602
Each answer restates registry values shown on this page.
What is NCT02773602?
NCT02773602 is a phase 4 interventional trial sponsored by The University of Texas Health Science Center, Houston. It studies Clonidine, Dexamethasone and Normal Saline in Postoperative Pain.
Who leads NCT02773602?
The registry names Samia N Khalil, (M.B; B.CH) (principal investigator, The University of Texas Health Science Center, Houston) as the overall official.
Where does NCT02773602 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT02773602 study?
The registered drug and biological interventions are Clonidine, Dexamethasone and Normal Saline.
When is NCT02773602 expected to complete?
The registry lists a primary completion date of 31 Dec 2016 and a study completion date of 31 Dec 2017. The sponsor last updated the record on 16 May 2016.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.